Previously, Eckel and colleagues studied a relatively homogenous population with obesity and T2D and found that MCT improved insulin sensitivity in patients who already have metabolic dysfunction in a monitored inpatient setting [31]. The gene discussed is INS; the disease is obesity disorder.